Safety and Tolerability of Wharton's Jelly-Derived Mesenchymal Stem Cells for Patients With Duchenne Muscular Dystrophy: A Phase 1 Clinical Study.
- DOI
- 10.3988/jcn.2024.0299
- Published
- 2025 Jan
- Container
- Journal of clinical neurology (Seoul, Korea)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3988/jcn.2024.0299,
title = {Safety and Tolerability of Wharton's Jelly-Derived Mesenchymal Stem Cells for Patients With Duchenne Muscular Dystrophy: A Phase 1 Clinical Study.},
author = {Lee J and Park SE and Kim M and Kim H and Kwon JY and Jeon HB and Chang JW and Lee J},
year = {2025},
journal = {Journal of clinical neurology (Seoul, Korea)},
doi = {10.3988/jcn.2024.0299},
url = {https://doi.org/10.3988/jcn.2024.0299}
}RIS
TY - JOUR TI - Safety and Tolerability of Wharton's Jelly-Derived Mesenchymal Stem Cells for Patients With Duchenne Muscular Dystrophy: A Phase 1 Clinical Study. AU - Lee J AU - Park SE AU - Kim M AU - Kim H AU - Kwon JY AU - Jeon HB AU - Chang JW AU - Lee J PY - 2025 JO - Journal of clinical neurology (Seoul, Korea) DO - 10.3988/jcn.2024.0299 UR - https://doi.org/10.3988/jcn.2024.0299 ER -
APA
J, L., SE, P., M, K., H, K., JY, K., HB, J., JW, C., & J, L. (2025). Safety and Tolerability of Wharton's Jelly-Derived Mesenchymal Stem Cells for Patients With Duchenne Muscular Dystrophy: A Phase 1 Clinical Study.. Journal of clinical neurology (Seoul, Korea). https://doi.org/10.3988/jcn.2024.0299
Source records
- pubmed · retrieved 2026-09-27T01:43:20.545Z
- europe-pmc · retrieved 2026-09-27T01:43:20.556Z